Biotangents secure funding to develop next generation mastitis testing

Published: 14 December 2020

Biotangents, based on Pentlands Science Park, have been awarded seed funding from CIEL (Centre for Innovation Excellence in Livestock) to work with researchers at the University of Edinburgh Roslin Institute.

This is part of the company's development of an in-clinic and on-farm diagnostic for mastitis and this research will differentiate between key mastitis-causing pathogens, meeting a critical industry-led need.

Mastitis is an inflammation of the mammary gland that is predominantly caused by a bacterial infection and is the most common and costly disease affecting the dairy industry. Because it can cause significant financial losses and adversely impact animal welfare, farmers and herd managers need quick diagnostic results so they can take fast and appropriate action.

In this project, researchers from the Roslin Institute will produce gene expression data for mastitis-causing pathogens and identify the most prevalent causes of mastitis in the UK, and also globally to meet our future international sales. This data will be used by our multi-disciplinary team, to develop the next generation of mastitis diagnostics.

This latest Biotangents innovation, for new diagnostic solutions for use in-clinic and on-farm, with global application, delivers the following benefits:

News Biotangents Mastitis Testing

 Find out more at Biotangents

Share

Latest tweets

follow us @MidlothScience

Pentlands Science Park

  • Bush Loan
  • Penicuik
  • Midlothian, EH26 0PZ

Park Manager: George Walker

T: +44 (0)131 445 5111

Email us

The Roslin Institute

  • The University of Edinburgh
  • Easter Bush
  • Midlothian, EH25 9RG

Enquiries: The Roslin Institute

T: +44 (0)131 651 9100

Email us